Lentiviral Vector CDMO Market Expected to Expand at 8% CAGR with Strategic Partnerships by 2030
The global lentiviral vector CDMO market is set to witness a growth rate of 8% in the next 5 years. Growing demand for gene and cell therapies; expanding pipeline of gene therapy products; technological advancements in lentiviral vector production; growing investments in biopharmaceutical R&D and increasing strategic partnerships and collaborations are some of the key factors […]
Continue Reading